Your browser doesn't support javascript.
loading
Clinical outcomes of gemtuzumab ozogamicin for relapsed acute myeloid leukemia: single-institution experience.
Hosono, Naoko; Ookura, Miyuki; Araie, Hiroaki; Morita, Mihoko; Itoh, Kazuhiro; Matsuda, Yasufumi; Yamauchi, Takahiro.
Afiliação
  • Hosono N; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan. hosono@u-fukui.ac.jp.
  • Ookura M; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
  • Araie H; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
  • Morita M; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
  • Itoh K; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
  • Matsuda Y; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
  • Yamauchi T; Department of Hematology and Oncology, University of Fukui, 23-3, Shimoaizuki, Fukui, Matsuoka, 910-1193, Japan.
Int J Hematol ; 113(3): 362-369, 2021 Mar.
Article em En | MEDLINE | ID: mdl-33219461
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Terapia de Salvação / Antineoplásicos Imunológicos / Gemtuzumab Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Terapia de Salvação / Antineoplásicos Imunológicos / Gemtuzumab Idioma: En Ano de publicação: 2021 Tipo de documento: Article